Jennifer Jarrett, Director, President and CEO: Damora Therapeutics DMRA Buy · Filed 09/28

Trade details

Type: Insider buy
Amount: $252,875
Shares · price: 12,500 sh · $20.23 a share
Held after: 512,500 sh
Stock: Damora Therapeutics DMRA
Person: Jennifer JarrettDirector, President and CEO
Trade date: 26/09/25
Filed: 26/09/28
Days to filing: 3 days

First buy since 2023

Insiders buying this week: 1 insiders
Holding change: +2.5%

Damora Therapeutics trades, last 26 weeks

What else happened in Damora Therapeutics around then

Filed or reported within 30 days of the trade day · 08/26~10/25

Jennifer Jarrett's recent trades

Jennifer JarrettOfficer
Planned saleArcus Biosciences
Planned sale
Arcus Biosciences
RCUS
$1.9M
77,793 sh
$1.9M
Filed 05/06
Traded 05/06
Jennifer JarrettOfficer
Planned saleArcus Biosciences
Planned sale
Arcus Biosciences
RCUS
$1.4M
53,826 sh
$1.4M
Filed 04/23
Traded 04/23
Jennifer JarrettOfficer
Planned saleArcus Biosciences
Planned sale
Arcus Biosciences
RCUS
$1.6M
70,000 sh
$1.6M
Filed 04/08
Traded 04/08
Jennifer JarrettCOO
Sell10b5-1 planArcus Biosciences
Sell10b5-1 plan
Arcus Biosciences
RCUS
$245.6K
11,225 sh
$245.6K
Filed 25/12/18
Traded 25/12/16
Jennifer JarrettCOO
Sell10b5-1 planArcus Biosciences
Sell10b5-1 plan
Arcus Biosciences
RCUS
$221.2K
9,983 sh
$221.2K
Filed 25/12/18
Traded 25/12/17